Biofabrication of 3D-printed, pre-cross-linked alginate dialdehyde–gelatin (ADA–GEL) scaffolds for an in vivo metastatic arteriovenous loop tumor model

Vascularized models mimicking tumor pathophysiology to investigate tumor characteristics are of high interest. The arteriovenous loop (AVL) model is an established method to vitalize bioengineered tissue grafts. In this model, an artificial vascular axis serves as the only connection between the living organism and the biomaterial. The objective of this study was to establish a three-dimensional (3D) printed, functional scaffold design for the AVL rodent model, in which human melanoma cells, derived from lymph node metastasis, are embedded in pre-cross-linked alginate dialdehyde-gelatin (ADA-GEL) and implanted in rats (N = 10) for 4 weeks. Bioink scaffolds were 3D-printed in two different shapes (n = 5), designed specifically for the AVL model's isolation chamber. Before implantation, the swelling behavior of the biofabricates was analyzed <i>in vitro</i>. The biocompatibility of the pre-cross-linked ADA-GEL and the impact of the scaffold-morphology were examined through macroscopic analysis and immunohistological stainings. The fluid uptake ratio of the hydrogel resulted in size extension, a finding which is highly relevant for the AVL model's closed system. Biofabricated scaffolds made of pre-cross-linked ADA-GEL remained stable <i>in vivo</i> and allowed for <i>de novo</i> fibrovascular tissue formation. The hypothesized biocompatibility of the analyzed hydrogel was confirmed. The two scaffold models exhibited differences regarding tumor growth and <i>de novo</i> fibrovascular tissue formation capacity. In both groups, metastatic cells were detected in the lymph nodes of rodents. The present study demonstrated that the AVL model is an excellent <i>in vivo</i> tool for melanoma research, combining biofabrication and vascularization with a high ability to replicate metastasis. At the same we conclude, that adapting the design of the biofabricated implants to the AVL model, depending specifically on the ink used, is of major importance.

Authors

Institutions

Publication Details

Journal
Frontiers in Bioengineering and Biotechnology
Published
2025-11-03
DOI
https://doi.org/10.3389/fbioe.2025.1657653
Primary Topic
3D Printing in Biomedical Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Biofabrication of 3D-printed, pre-cross-linked alginate dialdehyde–gelatin (ADA–GEL) scaffolds for an in vivo metastatic arteriovenous loop tumor model

Rafael Schmid, Annika Kengelbach‐Weigand, Anja‐Katrin Bosserhoff, Aldo Roberto Boccaccini et al.
Frontiers in Bioengineering and Biotechnology
3D Printing in Biomedical Research
article

Biofabrication of 3D-printed, pre-cross-linked alginate dialdehyde–gelatin (ADA–GEL) scaffolds for an in vivo metastatic arteriovenous loop tumor model

Rafael Schmid, Annika Kengelbach‐Weigand, Anja‐Katrin Bosserhoff, Aldo Roberto Boccaccini, Steven K. Schmidt, Stefanie Heltmann‐Meyer, Andreas Arkudas, Carolin Eckert, Markus V. Heppt, Raymund E. Horch, Jonas Röder, Evelin Sandor, Tannaz Karimi, Yvonne Kulicke
article en

Abstract

Vascularized models mimicking tumor pathophysiology to investigate tumor characteristics are of high interest. The arteriovenous loop (AVL) model is an established method to vitalize bioengineered tissue grafts. In this model, an artificial vascular axis serves as the only connection between the living organism and the biomaterial. The objective of this study was to establish a three-dimensional (3D) printed, functional scaffold design for the AVL rodent model, in which human melanoma cells, derived from lymph node metastasis, are embedded in pre-cross-linked alginate dialdehyde-gelatin (ADA-GEL) and implanted in rats (N = 10) for 4 weeks. Bioink scaffolds were 3D-printed in two different shapes (n = 5), designed specifically for the AVL model's isolation chamber. Before implantation, the swelling behavior of the biofabricates was analyzed <i>in vitro</i>. The biocompatibility of the pre-cross-linked ADA-GEL and the impact of the scaffold-morphology were examined through macroscopic analysis and immunohistological stainings. The fluid uptake ratio of the hydrogel resulted in size extension, a finding which is highly relevant for the AVL model's closed system. Biofabricated scaffolds made of pre-cross-linked ADA-GEL remained stable <i>in vivo</i> and allowed for <i>de novo</i> fibrovascular tissue formation. The hypothesized biocompatibility of the analyzed hydrogel was confirmed. The two scaffold models exhibited differences regarding tumor growth and <i>de novo</i> fibrovascular tissue formation capacity. In both groups, metastatic cells were detected in the lymph nodes of rodents. The present study demonstrated that the AVL model is an excellent <i>in vivo</i> tool for melanoma research, combining biofabrication and vascularization with a high ability to replicate metastasis. At the same we conclude, that adapting the design of the biofabricated implants to the AVL model, depending specifically on the ink used, is of major importance.

Frontiers in Bioengineering and BiotechnologyVol. 13
Friedrich-Alexander-Universität Erlangen-Nürnberg (DE), Universitätsklinikum Erlangen (DE), Dermatopathologie Friedrichshafen (DE), Comprehensive Cancer Center Erlangen (DE)
Friedrich-Alexander-Universität Erlangen-Nürnberg, Deutsche Forschungsgemeinschaft
Openalex Percentile: Top 69%
3D Printing in Biomedical Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.